共 50 条
Oesophageal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
被引:244
|作者:
Obermannova, R.
[1
]
Alsina, M.
[2
,3
]
Cervantes, A.
[4
,5
]
Leong, T.
[6
]
Lordick, F.
[7
]
Nilsson, M.
[8
,9
]
van Grieken, N. C. T.
[1
,10
]
Vogel, A.
[1
,11
]
Smyth, E. C.
[1
,2
,12
]
机构:
[1] Masaryk Univ, Masaryk Mem Canc Inst, Fac Med, Dept Comprehens Canc Care, Brno, Czech Republic
[2] Hosp Univ Navarra HUN, Dept Med Oncol, Pamplona, Spain
[3] Vall dHebron Inst Oncol, Gastrointestinal Tumours Grp, Barcelona, Spain
[4] Univ Valencia, INCL Biomed Res Inst, Dept Med Oncol, Valencia, Spain
[5] Inst Salud Carlos III, CIBERONC, Madrid, Spain
[6] Univ Melbourne, Peter MacCallum Canc Ctr, Sir Peter MacCallum Dept Oncol, Melbourne, Australia
[7] Leipzig Univ Med Ctr, Univ Canc Ctr Leipzig UCCL, Dept Med Oncol 2, Gastroenterol, Leipzig, Germany
[8] Karolinska Inst, Dept Clin Sci Intervent & Technol, Stockholm, Sweden
[9] Karolinska Univ Hosp, Dept Upper Abdominal Dis, Stockholm, Sweden
[10] Vrije Univ, Amsterdam Univ Med Ctr, Canc Ctr Amsterdam, Dept Pathol, Amsterdam, Netherlands
[11] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Hannover, Germany
[12] Cambridge Univ Hosp NHS Fdn Trust, Dept Oncol, Cambridge, England
关键词:
diagnosis;
ESMO Clinical Practice Guideline;
follow-up;
oesophageal cancer;
treatment;
SQUAMOUS-CELL CARCINOMA;
PHASE-III TRIAL;
MINIMALLY INVASIVE ESOPHAGECTOMY;
GASTROESOPHAGEAL JUNCTION;
DEFINITIVE CHEMORADIOTHERAPY;
PERIOPERATIVE CHEMOTHERAPY;
NEOADJUVANT CHEMOTHERAPY;
ENDOSCOPIC MANAGEMENT;
EUROPEAN-SOCIETY;
OPEN-LABEL;
D O I:
10.1016/j.annonc.2022.07.003
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
[No abstract available]
引用
收藏
页码:992 / 1004
页数:13
相关论文